Trial Profile
Multicenter Tolvaptan study For Uncontrolled volume overload in Japanese acute decompensated heart failure patients: A prospective observational multicenter cohort study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Decompensated heart failure
- Focus Adverse reactions; Therapeutic Use
- Acronyms MT FUJI
- 01 Jun 2017 Status changed from active, no longer recruiting to completed.
- 29 Dec 2016 Planned End Date changed to 31 Jan 2017.
- 13 Jul 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016.